Catalogue Number
BN-O1263
Analysis Method
Specification
98%(HPLC)
Storage
2-8°C
Molecular Weight
454.4
Appearance
Botanical Source
Structure Type
Category
SMILES
CC(=O)OCC1C(C(C(C(O1)OC2=CC=C(C=C2)CO)OC(=O)C)OC(=O)C)OC(=O)C
Synonyms
4-Cyanobenzyl alcohol/p-hydroxymethylbenzonitrile/4-hydroxymethylbenzenecarbonitrile/p-cyanobenzyl alcohol/4-(Hydroxymethyl)phenyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside/β-D-Glucopyranoside, 4-(hydroxymethyl)phenyl, tetraacetate
IUPAC Name
[(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[4-(hydroxymethyl)phenoxy]oxan-2-yl]methyl acetate
Density
1.3±0.1 g/cm3
Solubility
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Flash Point
184.0±23.6 °C
Boiling Point
551.4±50.0 °C at 760 mmHg
Melting Point
InChl
InChl Key
HGUDVDQXCUHOED-YMQHIKHWSA-N
WGK Germany
RID/ADR
HS Code Reference
Personal Projective Equipment
Correct Usage
For Reference Standard and R&D, Not for Human Use Directly.
Meta Tag
provides coniferyl ferulate(CAS#:64291-41-4) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate
No Technical Documents Available For This Product.
27650536
AIMS:
To investigate the protective effect of acetagastrodin on visual electrophysiology in patients with early-stage diabetes.
METHODS:
A prospective, randomized, controlled, double-blind trial was conducted. Subjects who were randomly assigned to either the treatment group or the control group were orally administered acetagastrodin or placebo, respectively, for 6 months. The quantity, mean amplitude and mean latency of oscillatory potentials (OPs) wavelets at baseline and 6 months were measured on electroretinogram (ERG), in all subjects.
RESULTS:
A total of 92 right eyes in 92 patients with type 2 diabetes, who were diagnosed for the first time, were enrolled. Each group consisted of 46 cases (46 eyes). There was no significant difference in baseline characteristic between treatment and control groups at baseline, but quantity in treatment group was more than that in control group at 6 months (P = 0.001). The mean amplitude of OPs was reduced in the control group 6 months later compared with treatment group (P = 0.001). As to mean latency of OPs, statistical difference was also detectable between the treatment group and control group 6 months later (P < 0.001). No statistical differences were found in hemoglobin between both groups at 6 months (P > 0.05).
CONCLUSIONS:
Electrophysiological changes would go on worsening even hemoglobin was under control during the initial stage of diabetes. Acetagastrodin treatment may be an effective treatment to protect retinal neurons against such functional impairment during the early stages of diabetes.
Acetagastrodin; Diabetic retinopathy; Electrophysiology; Neuropathy; Neuroprotection
Acetagastrodin effects on retinal oscillatory potentials in patients during the early stages of diabetes.
Yang X1, Xu J2, Liu J1, Ni N1, Mei Y3, Lei H1, Wang J4, Niu B5.
2017 Jan
2955659
[Influences of acetagastrodin on fetuses of mice and rats].
Xiong JM, Mo YQ, Liang B, Chen ZH, Deng SX.
1987 Jan
Description :
Empty ...